Gravity 360, Parent Company of Gravity Diagnostics, Acquires Med-Lake Laboratory, Expanding Its Healthcare Platform across the Southern United States

Gravity 360, Inc., the parent company of healthcare company Gravity Diagnostics, announces it has acquired Med-Lake Laboratory, LLC, a full-service clinical laboratory based in Milledgeville, Georgia. Founded in 2018, Med-Lake Laboratory is a CLIA-certified, CAP-accredited, high-complexity laboratory serving physician practices, skilled nursing facilities, behavioral health providers, judicial programs, and urgent care clinics across Georgia, Alabama,

Gravity 360, Parent Company of Gravity Diagnostics, Acquires Med-Lake Laboratory, Expanding Its Healthcare Platform across the Southern United States Read More »

BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities

BiomEdit, a pioneering animal health biotechnology company, announces it has acquired Folium Science’s technology platform and pipeline assets, including BiomElix® One, a poultry feed additive approved in Brazil. BiomEdit is pioneering a new class of genetically engineered bacterial biologics called Programmable Veterinary Biologics™, designed to perform targeted biological functions in animals. This acquisition adds Folium’s

BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities Read More »

American Healthcare REIT Buys NorCal Senior Housing Portfolio for $197M

American Healthcare REIT has completed the $197 million acquisition of a two-property portfolio of California senior housing assets. The communities include Sonrisa Senior Living and The Watermark at Almaden, which total 545 units. The transaction represents one of the largest senior housing portfolio sales in Northern California in recent years. The seller was a joint

American Healthcare REIT Buys NorCal Senior Housing Portfolio for $197M Read More »

Woodside Health Acquires Nansemond River Medical Center

Woodside Health is pleased to announce the acquisition of Nansemond River Medical Center at 150 Burnetts Way in Suffolk, Virginia. This investment is part of the continued joint venture between Woodside Health and Heitman. Located adjacent to Sentara Obici Hospital, Nansemond River Medical Center benefits from its strategic position within an established and growing medical

Woodside Health Acquires Nansemond River Medical Center Read More »

The Landes Group Completes Acquisition of Encore Medical Center, Finalizes Long-Term Lease with UAMS

The Landes Group, a Dallas-based real estate investment firm specializing in healthcare real estate and capital solutions, announces it has completed the acquisition of Encore Medical Center, a 108,055-square-foot hospital in Bryant, Arkansas, and finalized a long-term lease agreement with the University of Arkansas for Medical Sciences (UAMS), which will operate the facility. The acquisition

The Landes Group Completes Acquisition of Encore Medical Center, Finalizes Long-Term Lease with UAMS Read More »

Home Health M&A Activity Rises as Proposed Rule, Provider Moratorium Shape Market

After four consecutive years of decline, home health and hospice dealmaking is gaining momentum — and the proposed CY2027 home health rule and the Medicare enrollment moratoria could propel activity even higher through 2027. Home health and hospice dealmaking could spike not only in volume, but also in valuation, according to a recent report from

Home Health M&A Activity Rises as Proposed Rule, Provider Moratorium Shape Market Read More »

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors

McKesson Corporation has signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialization services, in a transaction valued at approximately $2.25 billion. Brian Tyler, chair and chief executive officer, McKesson, said in a press release, “This acquisition represents another meaningful step in advancing our oncology and multispecialty

What the McKesson-Precision Medicine Deal Signals for Trial Sponsors Read More »

Costs Tied to No Surprises Act’s IDR Process Hit $22B in 2025, Study Finds

Total costs associated wth the No Surprises Act’s dispute resolution process reached $22.4 billion at the end of 2025, according to a new analysis. Researchers at the Center on Health Insurance Reforms at Georgetown University’s McCourt School of Public Policy dove into the latest public data on independent dispute resolution (IDR) from the federal government,

Costs Tied to No Surprises Act’s IDR Process Hit $22B in 2025, Study Finds Read More »

As Costs Rise, C-Suite Is Getting More Involved in Healthcare: Employer Survey

Sustained cost pressure is forcing employers to reassess their approach to healthcare, according to a new survey. The Business Group on Health released its annual Employer Healthcare Strategy Survey, which found that firms anticipate a median cost increase of 9.2% in 2027. Plan changes and updates would likely offset that, resulting in an 8% increase,

As Costs Rise, C-Suite Is Getting More Involved in Healthcare: Employer Survey Read More »

Scroll to Top